← Back to patent-cliff list
CAS 53053-54-6
N-[4-(2-Amino-4-oxo-1,4-dihydropteridin-6-ylmethylamino)-3,5-dideuterobenzoyl]-L-glutamic acid
Codes: Folic Acid-027
Application context (from source-drug indications)
Essential hypertensionEnalapril Maleate/Folic AcidMegaloblastic anaemiaFolic AcidFolate deficiencyFolic AcidNeural tube defectFolic AcidAnaemiaFolic AcidHot flushesFolic AcidHyperhomocysteinaemiaFolic Acid
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Enalapril Maleate/Folic Acid | Tier C — Watch / trade | - |
| Folic Acid | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
N-[4-(2-Amino-4-oxo-1,4-dihydropteridin-6-ylmethylamino)-3,5-dibromobenzoyl]-L-glutamic acid→N-[4-(2-Amino-4-oxo-1,4-dihydropteridin-6-ylmethylamino)-3,5-dideuterobenzoyl]-L-glutamic acid
N-[4-(2-Amino-4-oxo-1,4-dihydropteridin-6-ylmethylamino)-3,5-dibromobenzoyl]-L-glutamic acid→N-[4-(2-Amino-4-oxo-1,4-dihydropteridin-6-ylmethylamino)-3,5-dideuterobenzoyl]-L-glutamic acid
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.